Following news from the company, Leede Jones Gable analyst Douglas Loe remains bullish about Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:CRDL) On September 19, CRDL announced that all collaborating clinical research centers are now initiated and eligible to enroll patients in its Phase 2 trail for Acute Myocarditis trial, Archer. “Initiation […]
After a swoon in its share price that began several months ago, Raymond James analyst Rahul Sarugaser has upgrade Profound Medical (Profound Medical Stock Quote, Chart, News, Analysts, Financials NASDAQ:PROF). In a research update to clients September 18, Sarugaser upgraded PROF from “Outperform 2” to “Strong Buy 1” and maintained his $20.00 price target […]
Share
Tweet
Share
